Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in “real-world” clinical practice : A propensity-matched analysis of 76,940 patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in “real-world” clinical practice ; volume:117 ; number:06 ; year:2017 ; pages:1072-1082
Thrombosis and haemostasis ; 117, Heft 06 (2017), 1072-1082
- Contributor
-
Li, Xiaoyan
Deitelzweig, Steve
Keshishian, Allison
Hamilton, Melissa
Horblyuk, Ruslan
Gupta, Kiran
Luo, Xuemei
Mardekian, Jack
Friend, Keith
Nadkarni, Anagha
Pan, Xianying
Lip, Gregory Y. H.
- DOI
-
10.1160/TH17-01-0068
- URN
-
urn:nbn:de:101:1-2019041408371805575047
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Li, Xiaoyan
- Deitelzweig, Steve
- Keshishian, Allison
- Hamilton, Melissa
- Horblyuk, Ruslan
- Gupta, Kiran
- Luo, Xuemei
- Mardekian, Jack
- Friend, Keith
- Nadkarni, Anagha
- Pan, Xianying
- Lip, Gregory Y. H.
Other Objects (12)
Evaluation of Apixaban standard dosing in underweight patients with non-valvular atrial fibrillation: a retrospective cohort study
Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
Use, Persistence, Efficacy, and Safety of Apixaban in Patients with Non-Valvular Atrial Fibrillation in Unselected Patients in Germany. Results of the Prospective Apixaban in Atrial Fibrillation (APAF) Registry
Correction: Psychiatric symptoms in patients with non-valvular atrial fibrillation
Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation
Morphology and location of thrombus and sludge in patients with non-valvular atrial fibrillation
Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation
MicroRNA profiling in the left atrium in patients with non-valvular paroxysmal atrial fibrillation
Edoxaban in patients with non-valvular atrial fibrillation after percutaneous coronary intervention: ENCOURAGE-AF design
Evaluation of Apixaban standard dosing in underweight patients with non-valvular atrial fibrillation: a retrospective cohort study
Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
Use, Persistence, Efficacy, and Safety of Apixaban in Patients with Non-Valvular Atrial Fibrillation in Unselected Patients in Germany. Results of the Prospective Apixaban in Atrial Fibrillation (APAF) Registry
Correction: Psychiatric symptoms in patients with non-valvular atrial fibrillation
Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation
Morphology and location of thrombus and sludge in patients with non-valvular atrial fibrillation
Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation
MicroRNA profiling in the left atrium in patients with non-valvular paroxysmal atrial fibrillation
Edoxaban in patients with non-valvular atrial fibrillation after percutaneous coronary intervention: ENCOURAGE-AF design
Evaluation of Apixaban standard dosing in underweight patients with non-valvular atrial fibrillation: a retrospective cohort study
Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
Use, Persistence, Efficacy, and Safety of Apixaban in Patients with Non-Valvular Atrial Fibrillation in Unselected Patients in Germany. Results of the Prospective Apixaban in Atrial Fibrillation (APAF) Registry
Correction: Psychiatric symptoms in patients with non-valvular atrial fibrillation
Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation
Morphology and location of thrombus and sludge in patients with non-valvular atrial fibrillation
Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation
MicroRNA profiling in the left atrium in patients with non-valvular paroxysmal atrial fibrillation